search
Back to results

Intracytoplasmic Sperm Injection Preparation in Infertile Women

Primary Purpose

Infertility

Status
Unknown status
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Doxycycline before ICSI
Sponsored by
Aljazeera Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Infertility

Eligibility Criteria

20 Years - 42 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Women who have infertility with age between 20 -42 years

Exclusion Criteria:

  • women who has ovarian or endometrial factor of infertility

Sites / Locations

  • AlgazeerahRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

No Intervention

Arm Label

Doxycycline before ICSI

control group

Arm Description

extra medications (Doxycycline ) group before ICSI : in which Women who will receive the Doxyxycline before ICSI Intervention : Women will receive Doxycycline before ICSI

control group : No intervention : in which Women willnot receive the extra medications (Doxycycline ) before ICSI

Outcomes

Primary Outcome Measures

the number of women who will have successful ICSI
The number of women who will get pregnant after ICSI with extra treatment

Secondary Outcome Measures

Full Information

First Posted
January 25, 2019
Last Updated
August 4, 2019
Sponsor
Aljazeera Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03824340
Brief Title
Intracytoplasmic Sperm Injection Preparation in Infertile Women
Official Title
Intracytoplasmic Sperm Injection Preparation in Infertile Women With Unexplained Infertility
Study Type
Interventional

2. Study Status

Record Verification Date
August 2019
Overall Recruitment Status
Unknown status
Study Start Date
January 30, 2019 (Actual)
Primary Completion Date
November 30, 2019 (Anticipated)
Study Completion Date
January 1, 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Aljazeera Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Infertility is a common gynecological problem is women
Detailed Description
Intracytoplasmic sperm injection is one of the aisted reproduction techniques that help to solve this problem

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infertility

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
A randomized controlled study
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
500 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Doxycycline before ICSI
Arm Type
Active Comparator
Arm Description
extra medications (Doxycycline ) group before ICSI : in which Women who will receive the Doxyxycline before ICSI Intervention : Women will receive Doxycycline before ICSI
Arm Title
control group
Arm Type
No Intervention
Arm Description
control group : No intervention : in which Women willnot receive the extra medications (Doxycycline ) before ICSI
Intervention Type
Drug
Intervention Name(s)
Doxycycline before ICSI
Other Intervention Name(s)
Medical treatment with Doxycycline
Intervention Description
Extra medication (Doxycycline ) group before ICSI :,women who will receive more medications (Doxycycline ) before starting the ICSI process
Primary Outcome Measure Information:
Title
the number of women who will have successful ICSI
Description
The number of women who will get pregnant after ICSI with extra treatment
Time Frame
within 4 months

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
infertile women
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
42 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Women who have infertility with age between 20 -42 years Exclusion Criteria: women who has ovarian or endometrial factor of infertility
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mahmoud Alalfy, PhD
Phone
01002611058
Email
mahmoudalalfy@ymail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mahmoud Alalfy, PhD
Organizational Affiliation
Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt
Official's Role
Principal Investigator
Facility Information:
Facility Name
Algazeerah
City
Giza
Country
Egypt
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mahmoud Alalfy, master
Phone
+201002611058
Email
mahmoudalalfy@ymail.com
First Name & Middle Initial & Last Name & Degree
Ahmed Elgazzar, M.D
Phone
+201014005959
First Name & Middle Initial & Last Name & Degree
Mahmoud Alalfy, master

12. IPD Sharing Statement

Learn more about this trial

Intracytoplasmic Sperm Injection Preparation in Infertile Women

We'll reach out to this number within 24 hrs